Guanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August

Bulletin Express

08/17

Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:

1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.

2. Considering the declaration and payment of an interim dividend, subject to board approval.

3. Addressing any other routine business matters.

The notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/1179225137"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1179225137\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1179225137?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-17 17:07","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1179225137","market":"us","top_or_hot":-1,"title":"Guanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August","media":"Bulletin Express","content":"<p>Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:</p>\n<p>1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.</p>\n<p>2. Considering the declaration and payment of an interim dividend, subject to board approval.</p>\n<p>3. Addressing any other routine business matters.</p>\n<p>The notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Guanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGuanze Medical to Review H1 2026 Interim Results and Potential Dividend on 31 August\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time smaller\">2026-08-17 17:07</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:</p>\n<p>1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.</p>\n<p>2. Considering the declaration and payment of an interim dividend, subject to board approval.</p>\n<p>3. Addressing any other routine business matters.</p>\n<p>The notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02427","symbol_name":"GUANZE MEDICAL","start_time":0,"source_url":"","article_id":"1179225137","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1179225137","pubTimestamp":1786957628,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items: 1. Assessing and, if appropriate, approving the...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02427":"GUANZE MEDICAL"},"translate_title":"冠泽医疗将于8月31日审阅2026年上半年中期业绩及潜在股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02427":1},"content_text":"Guanze Medical Information Industry (Holding) Co., Ltd. has scheduled a board meeting for Monday, 31 August 2026. The agenda includes three key items:\n1. Assessing and, if appropriate, approving the unaudited consolidated interim results for the six-month period ended 30 June 2026.\n2. Considering the declaration and payment of an interim dividend, subject to board approval.\n3. Addressing any other routine business matters.\nThe notice, dated 17 August 2026, was signed by Chairwoman Jiang Zeman on behalf of the board. The company’s current board comprises three executive directors—Jiang Zeman, Qin Jingying and Meng Xianzhen—and three independent non-executive directors—Dr. Zhao Bin, Dr. Chang Shiwang and Dr. Wong Man Hin Raymond.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"dataReport,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}